サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1206306

中東・アフリカのインフルエンザワクチン市場の2028年までの予測-地域分析- ワクチンタイプ、ウイルスタイプ、技術、投与経路、ターゲットグループ別

Middle East & Africa Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Vaccine Type, Virus Type, Technology, Route of Administration, and Target Group
出版日: | 発行: The Insight Partners | ページ情報: 英文 135 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
中東・アフリカのインフルエンザワクチン市場の2028年までの予測-地域分析- ワクチンタイプ、ウイルスタイプ、技術、投与経路、ターゲットグループ別
出版日: 2023年01月10日
発行: The Insight Partners
ページ情報: 英文 135 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中東・アフリカのインフルエンザワクチン市場は、2022年の3億7,435万米ドルから2028年には5億3,385万米ドルに成長すると予測、2022年から2028年までのCAGRは6.1%と推定されます。

インフルエンザワクチン接種を推進する政府支援の増加が、予測期間中に中東・アフリカのインフルエンザワクチン市場を活性化する

インフルエンザワクチン市場の主要企業は、独自の技術に基づくドラッグデリバリーや生物学的パイプラインに関する複数のプロジェクトを持っています。ドラッグデリバリーにおける最も進んだ候補集団は、2つのフェーズI試験を完了しました。また、パイプラインには、前臨床評価を完了した多数の化合物が含まれています。パイプライン候補は、革新的なワクチンを開発するために、免疫系、ヒト遺伝学、最先端技術の科学を解き明かすことに重点を置いています。各社は、インフルエンザを含む感染症に対する新しいワクチンや特定の薬剤を開発・導入するために、科学的・技術的に優れた投資を行っています。パイプラインにあるワクチンやウイルス治療薬の候補は、中東・アフリカで最も差し迫った健康上の脅威に迅速かつ特異的に対応することができます。このように、インフルエンザワクチンの強力なパイプライン候補は、中東・アフリカのインフルエンザワクチン市場の最新動向となっています。

市場概要

中東＆アフリカのインフルエンザワクチン市場は、UAE、サウジアラビア、南アフリカ、その他中東＆アフリカに区分されます。2022年には、南アフリカが同地域のインフルエンザワクチン市場最大となりました。中東・アフリカのインフルエンザワクチン市場は、予測期間中にCAGR 6.1%で成長すると予測されています。インフルエンザワクチン市場は、人口基盤の増加、インフルエンザ患者の増加、地域全体での調査研究の増加、ヘルスケア施設の増加などにより、成長が期待されています。

中東・アフリカインフルエンザワクチン市場の収益と2028年までの予測（百万米ドル）

中東・アフリカのインフルエンザワクチン市場のセグメンテーション

中東・アフリカのインフルエンザワクチン市場は、ワクチンタイプ、ウイルスタイプ、技術、投与経路、ターゲットグループ、国に基づいてセグメント化されています。

ワクチンタイプに基づき、中東・アフリカのインフルエンザワクチン市場は4価ワクチンと3価ワクチンに二分化されます。4価ワクチンセグメントは、2022年に市場でより大きなシェアを登録しました。

ウイルスタイプに基づき、中東・アフリカのインフルエンザワクチン市場はインフルエンザウイルスA型とインフルエンザウイルスB型に二分され、2022年にはインフルエンザウイルスA型セグメントが市場でより大きなシェアを占めました。

技術に基づき、中東・アフリカのインフルエンザワクチン市場は、卵ベースと細胞ベースに分けられます。2022年の市場では、卵ベースのセグメントがより大きなシェアを占めています。

投与経路に基づき、中東・アフリカのインフルエンザワクチン市場は、注射と鼻腔スプレーに分けられます。2022年の市場では、注射剤がより大きなシェアを占めています。

ターゲットグループに基づき、中東・アフリカのインフルエンザワクチン市場は、乳児、小児、成人、高齢者に区分されます。2022年の市場では、乳幼児セグメントが最も大きなシェアを占めています。

国別では、中東＆アフリカのインフルエンザワクチン市場は、サウジアラビア、UAE、南アフリカ、その他中東＆アフリカに区分されます。2022年はサウジアラビアが市場を独占しました。

アストラゼネカ、グラクソ・スミスクラインplc.、三菱化学グループ、MYLAN N.V.、サノフィ、SEQIRUS、Serum Institute of India Pvt. Ltdが中東・アフリカのインフルエンザワクチン市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

  • 調査範囲
  • 洞察パートナーズの調査報告書ガイダンス
  • 市場セグメンテーション
    • 中東・アフリカのインフルエンザワクチン市場：ワクチンタイプ別
    • 中東・アフリカ地域のインフルエンザワクチン市場- ウイルスタイプ別
    • 中東・アフリカ地域のインフルエンザワクチン市場- 技術別
    • 中東・アフリカのインフルエンザワクチン市場：投与経路別
    • 中東・アフリカのインフルエンザワクチン市場：ターゲットグループ別
    • 中東・アフリカのインフルエンザワクチン市場：国別

第2章 中東・アフリカのインフルエンザワクチン市場- 重要なポイント

第3章 調査手法

  • 調査対象
  • 2次調査
  • 1次調査

第4章 中東・アフリカのインフルエンザワクチン市場：マーケット情勢

  • PEST分析
    • 中東・アフリカのPEST分析
  • 専門家別オピニオン

第5章 中東・アフリカのインフルエンザワクチン市場- 主要な市場力学

  • 市場促進要因
    • インフルエンザワクチン接種を促進するための政府支援の増加
    • トップ企業と政府別投資の増加
  • 市場抑制要因
    • ワクチン開発コストの高さ
  • 市場機会
    • 新興国
  • 今後の動向
    • インフルエンザワクチンの強力な候補パイプライン
  • インパクトのある分析

第6章 インフルエンザワクチン市場-中東・アフリカの分析

  • 中東・アフリカのインフルエンザワクチン市場：国別予測・分析
  • 中東・アフリカのインフルエンザワクチン市場収益と予測・分析
    • 中東・アフリカ：インフルエンザワクチン市場、2019年～2028年

第7章 中東・アフリカのインフルエンザワクチン市場の分析と2028年までの予測- ワクチンタイプ別

  • 中東・アフリカのインフルエンザワクチン市場、ワクチンタイプ別2022年・2028年（%）
  • 4価ワクチン
  • 3価ワクチン

第8章 中東・アフリカ地域のインフルエンザワクチン市場の分析と2028年までの予測：ウイルスタイプ別

  • 中東・アフリカのインフルエンザワクチン市場：ウイルスタイプ別2022年・2028年（%）
  • インフルエンザウイルスA型
  • インフルエンザウイルスB型

第9章 中東・アフリカインフルエンザワクチン市場の分析と2028年までの予測：技術別

  • 中東・アフリカのインフルエンザワクチン市場：技術別2022年・2028年（%）
  • 卵子ベース
  • セルベース

第10章 中東・アフリカのインフルエンザワクチン市場の分析と2028年までの予測：投与経路別

  • 中東・アフリカのインフルエンザワクチン市場：投与経路別2022年・2028年（%）
  • 注射剤
  • 鼻腔スプレー

第11章 中東・アフリカのインフルエンザワクチン市場の分析と2028年までの予測：ターゲットグループ別

  • 中東・アフリカのインフルエンザワクチン市場：ターゲットグループ別2022年・2028年（%）
  • 乳幼児
  • 小児
  • 成人
  • 高齢者

第12章 中東・アフリカのインフルエンザワクチン市場の分析と2028年までの予測：国別分析

    • 中東・アフリカ地域
      • サウジアラビア
      • UAE
      • 南アフリカ共和国
      • その他中東とアフリカ

第13章 中東・アフリカのインフルエンザワクチン市場-業界情勢

  • インフルエンザワクチン市場の成長戦略、2021年～2028年
  • 無機的な成長戦略
  • 有機的成長戦略

第14章 企業プロファイル

  • SEQIRUS
  • Sanofi
  • GlaxoSmithKline plc.
  • Mitsubishi Chemical Group Corporation
  • Serum Institute of India Pvt. Ltd
  • MYLAN N.V.
  • AstraZeneca

第15章 付録

  • The Insight Partners について
  • 用語集
図表

List Of Tables

  • Table 1. Middle East & Africa Influenza Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
  • Table 2. Middle East & Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 3. Middle East & Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 4. Middle East & Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 5. Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 6. Middle East & Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 7. Saudi Arabia Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 8. Saudi Arabia Influenza Vaccine Market, by Virus Type- Revenue and Forecast to 2028 (USD Million)
  • Table 9. Saudi Arabia Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 10. Saudi Arabia Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 11. Saudi Arabia Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 12. UAE Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 13. UAE Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 14. UAE Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 15. UAE Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 16. UAE Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 17. South Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 18. South Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 19. South Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 20. South Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 21. South Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 22. Rest of Middle East & Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 23. Rest of Middle East & Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 24. Rest of Middle East & Africa Influenza Vaccine Market, by Technology- Revenue and Forecast to 2028 (USD Million)
  • Table 25. Rest of Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 26. Rest of Middle East & Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 27. Recent Inorganic Growth Strategies in the Influenza Vaccine Market
  • Table 28. Recent Organic Growth Strategies in the Influenza Vaccine Market
  • Table 29. Glossary of Terms, Influenza Vaccines Market

List Of Figures

  • Figure 1. Middle East & Africa Influenza Vaccines Market Segmentation
  • Figure 2. Middle East & Africa Influenza Vaccines Market Segmentation, by Country
  • Figure 3. Middle East & Africa Influenza Vaccines Market Overview
  • Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in Middle East & Africa Influenza Vaccines Market
  • Figure 5. Saudi Arabia Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Middle East and Africa: PEST Analysis
  • Figure 7. Experts Opinion
  • Figure 8. Middle East & Africa Influenza Vaccines Market - Revenue Forecasts and Analysis - 2020- 2028
  • Figure 9. Middle East & Africa Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
  • Figure 10. Quadrivalent Vaccines: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 11. Trivalent Vaccines: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 12. Middle East & Africa Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
  • Figure 13. Influenza Virus Type A : Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 14. Influenza Virus Type B: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 15. Middle East & Africa Influenza Vaccines Market, by Technology 2022 & 2028 (%)
  • Figure 16. Egg-based: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 17. Cell-Based: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 18. Middle East & Africa Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
  • Figure 19. Injection: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 20. Nasal Spray: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 21. Middle East & Africa Influenza Vaccines Market, by Target Group 2022 & 2028 (%)
  • Figure 22. Infants : Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 23. Children: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 24. Adults: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 25. Elderly People: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 26. Middle East & Africa: Influenza Vaccine Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 27. Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
  • Figure 28. Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 29. UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 30. South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 31. Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 32. Growth Strategies in the Influenza Vaccine Market, 2021-2028
目次
Product Code: BMIRE00026955

The Middle East & Africa influenza vaccines market is expected to grow from US$ 374.35 million in 2022 to US$ 533.85 million by 2028; it is estimated to grow at a CAGR of 6.1% from 2022 to 2028.

Increase in Government Support to Promote Influenza Vaccination to Bolster Middle East & Africa Influenza Vaccines Market During Forecast Period

Leading players in the influenza vaccines market have multiple projects on drug delivery and biological pipelines based on proprietary technology. The most advanced candidate population in drug delivery completed 2 Phase I studies. The pipeline also includes a large number of compounds that have completed preclinical evaluation. Pipeline candidates are focused on unlocking the science of the immune system, human genetics, and cutting-edge technologies to develop innovative vaccines. Companies are investing in scientific and technical excellence to develop and introduce new vaccines and specific drugs against infectious diseases, including influenza. Vaccines and viral therapeutic candidates in the pipeline are capable of rapidly and specifically responding to the most pressing health threats in the Middle East & Africa. Thus, strong pipeline candidates for influenza vaccines are the latest trend in the Middle East & Africa influenza vaccines market.

Market Overview

The Middle East & Africa influenza vaccines market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. In 2022, South Africa was the largest market for influenza vaccines in the region. The market for influenza vaccines in the Middle East & Africa is anticipated to grow at a CAGR of 6.1% during the forecast period. The influenza vaccines market is expected to grow due to the rising population base, increasing cases of influenza, growing research studies across the region, and increasing healthcare facilities.

Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Influenza Vaccines Market Segmentation

The Middle East & Africa influenza vaccines market is segmented on the basis of vaccine type, virus type, technology, route of administration, target group, and country.

Based on vaccine type, the Middle East & Africa influenza vaccines market is bifurcated into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered a larger share of the market in 2022.

Based on virus type, the Middle East & Africa influenza vaccines market is bifurcated into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger share of the market in 2022.

Based on technology, the Middle East & Africa influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger share of the market in 2022.

Based on route of administration, the Middle East & Africa influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger share of the market in 2022.

Based on target group, the Middle East & Africa influenza vaccines market is segmented into infants, children, adults, and elderly people. The infants segment held the largest share of the market in 2022.

Based on country, the Middle East & Africa influenza vaccines market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the market in 2022.

AstraZeneca; GlaxoSmithKline plc.; Mitsubishi Chemical Group Corporation; MYLAN N.V.; Sanofi; SEQIRUS; and Serum Institute of India Pvt. Ltd are the leading companies operating in the Middle East & Africa influenza vaccines market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa influenza vaccines market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa influenza vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Middle East & Africa Influenza Vaccines Market - By Vaccine Type
    • 1.3.2 Middle East & Africa Influenza Vaccines Market - By Virus Type
    • 1.3.3 Middle East & Africa Influenza Vaccines Market - By Technology
    • 1.3.4 Middle East & Africa Influenza Vaccines Market - By Route of Administration
    • 1.3.5 Middle East & Africa Influenza Vaccines Market - By Target Group
    • 1.3.6 Middle East & Africa Influenza Vaccines Market - By Country

2. Middle East & Africa Influenza Vaccines Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Middle East & Africa Influenza Vaccines Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Middle East and Africa PEST Analysis
  • 4.3 Experts Opinion

5. Middle East & Africa Influenza Vaccines Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increase in Government Support to Promote Influenza Vaccination
    • 5.1.2 Increasing Investment by Top Market Players and Governments
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Vaccine Development
  • 5.3 Market Opportunities
    • 5.3.1 Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Strong Pipeline Candidates for Influenza Vaccines
  • 5.5 Impact Analysis

6. Influenza Vaccine Market - Middle East & Africa Analysis

  • 6.1 Middle East & Africa Influenza Vaccines Market, By Country - Forecasts And Analysis
  • 6.2 Middle East & Africa Influenza Vaccines Market Revenue Forecasts And Analysis
    • 6.2.1 Middle East & Africa: Influenza Vaccines Market, 2019-2028 (US$ Million)

7. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Vaccine Type

  • 7.1 Overview
  • 7.2 Middle East & Africa Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
    • 7.2.1 Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
  • 7.3 Quadrivalent Vaccines
    • 7.3.1 Overview
    • 7.3.2 Quadrivalent Vaccines : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.4 Trivalent Vaccines
    • 7.4.1 Overview
    • 7.4.2 Trivalent Vaccines : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Virus Type

  • 8.1 Overview
  • 8.2 Middle East & Africa Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
    • 8.2.1 Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
  • 8.3 Influenza Virus Type A
    • 8.3.1 Overview
    • 8.3.2 Influenza Virus Type A : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.4 Influenza Virus Type B
    • 8.4.1 Overview
    • 8.4.2 Influenza Virus Type B : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Technology

  • 9.1 Overview
  • 9.2 Middle East & Africa Influenza Vaccines Market, By Technology 2022 & 2028 (%)
    • 9.2.1 Middle East & Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • 9.3 Egg-based
    • 9.3.1 Overview
    • 9.3.2 Egg-based : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.4 Cell-based
    • 9.4.1 Overview
    • 9.4.2 Cell-Based : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Route of Administration

  • 10.1 Overview
  • 10.2 Middle East & Africa Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
    • 10.2.1 Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • 10.3 Injection
    • 10.3.1 Overview
    • 10.3.2 Injection : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.4 Nasal Spray
    • 10.4.1 Overview
    • 10.4.2 Nasal Spray: Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Target Group

  • 11.1 Overview
  • 11.2 Middle East & Africa Influenza Vaccines Market, By Target Group 2022 & 2028 (%)
    • 11.2.1 Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  • 11.3 Infants
    • 11.3.1 Overview
    • 11.3.2 Infants : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.4 Children
    • 11.4.1 Overview
    • 11.4.2 Children: Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.5 Adults
    • 11.5.1 Overview
    • 11.5.2 Adults : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.6 Elderly People
    • 11.6.1 Overview
    • 11.6.2 Elderly People: Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

12. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - Country Analysis

  • 12.1 Middle East & Africa Influenza Vaccine Market Revenue and Forecasts To 2028
    • 12.1.1 Overview
    • 12.1.2 Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
      • 12.1.2.1 Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.1.2.1.1 Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.1.2.1.2 Saudi Arabia: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.1.2.1.3 Saudi Arabia: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.1.2.1.4 Saudi Arabia Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
        • 12.1.2.1.5 Saudi Arabia Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
        • 12.1.2.1.6 Saudi Arabia: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.1.2.2 UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.1.2.2.1 UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.1.2.2.2 UAE: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.1.2.2.3 UAE: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.1.2.2.4 UAE Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
        • 12.1.2.2.5 UAE Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
        • 12.1.2.2.6 UAE: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.1.2.3 South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.1.2.3.1 South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.1.2.3.2 South Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.1.2.3.3 South Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.1.2.3.4 South Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
        • 12.1.2.3.5 South Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
        • 12.1.2.3.6 South Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.1.2.4 Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.1.2.4.1 Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.1.2.4.2 Rest of Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.1.2.4.3 Rest of Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.1.2.4.4 Rest of Middle East & Africa: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
        • 12.1.2.4.5 Rest of Middle East & Africa: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
        • 12.1.2.4.6 Rest of Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)

13. Middle East & Africa Influenza Vaccine Market -Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028
  • 13.3 Inorganic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Organic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 SEQIRUS
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Sanofi
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 GlaxoSmithKline plc.
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Mitsubishi Chemical Group Corporation
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Serum Institute of India Pvt. Ltd
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 MYLAN N.V.
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 AstraZeneca
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms